The company
Passage Bio, Inc.
PASG · Nasdaq
PASG stood above a rising 150-day average in 15 of the last 52 weekly readings, and has been out of that trend for the last 26 weeks. It is 35.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 26
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $412K
- Insider sales, 12 months
- $226K
- Officials’ trades on record
- 0
- Institutions holding
- 27 (-4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Lynx1 Capital Management Lp10% owner | bought | 50,055at $4.12 | 25 Jun 2026filed 29 Jun 2026 |
| William ChouPRESIDENT AND CEO | sold | 4,076at $18.44 | 8 Jan 2026filed 12 Jan 2026 |
| Kathleen BorthwickCFO | sold | 2,062at $18.44 | 8 Jan 2026filed 12 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 2,886,125$4.3M | +2,886,125 |
| Lynx1 Capital Management LPadded · filed 12 Aug 2026 | 673,759$3.3M | +50,055+8.0% |
| VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026 | 113,964$556K | 00.0% |
| Balyasny Asset Management L.P.new · filed 14 Aug 2026 | 107,025$522K | +107,025 |
| Ikarian Capital, LLCadded · filed 14 Aug 2026 | 99,517$486K | +31,393+46.1% |
| Yiheng Capital Management, L.P.unchanged · filed 14 Aug 2026 | 86,097$420K | 00.0% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 47,892$234K | -85,720−64.2% |
| Erste Asset Management GmbHreduced · filed 28 Jul 2026 | 40,665$197K | -44,597−52.3% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 37,026$181K | -4,354−10.5% |
| Verdad Advisers, LPadded · filed 14 Aug 2026 | 30,728$150K | +8,600+38.9% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.